Literature DB >> 12021368

Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication.

William R Addison1, Kathie-Anne Walters, Winnie W S Wong, John S Wilson, Danuta Madej, Lawrence D Jewell, D Lorne J Tyrrell.   

Abstract

Covalently closed circular DNA (cccDNA) is a crucial intermediate in the replication of hepadnaviruses. We inhibited the replication of duck hepatitis B virus in congenitally infected ducks with a combination of lamivudine and a dideoxyguanosine prodrug. Inhibition of viral replication should prevent renewal of the cccDNA pool, and its decay was measured in liver biopsy samples collected over a 5-month period. In three ducks, the cccDNA pools declined exponentially, with half-lives ranging from 35 to 57 days. In two others, the pools declined exponentially for about 70 days but then stabilized at about 6 copies/diploid genome. The selection of drug-resistant virus mutants is an unlikely explanation for this unexpected stabilization of cccDNA levels. Liver sections stained for the cell division marker PCNA showed that animals in which cccDNA loss was continuous had significantly greater numbers of PCNA-positive nuclei than did those animals in which cccDNA levels had plateaued.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021368      PMCID: PMC136192          DOI: 10.1128/jvi.76.12.6356-6363.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Low dynamic state of viral competition in a chronic avian hepadnavirus infection.

Authors:  Y Y Zhang; J Summers
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.

Authors:  K S Gutfreund; M Williams; R George; V G Bain; M M Ma; E M Yoshida; J P Villeneuve; K P Fischer; D L Tyrrel
Journal:  J Hepatol       Date:  2000-09       Impact factor: 25.083

Review 3.  Viral DNA synthesis.

Authors:  C Seeger; J Summers; W S Mason
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

4.  Experimental in ovo transmission of duck hepatitis B virus.

Authors:  K N Tsiquaye; M Rapicetta; T F McCaul; A J Zuckerman
Journal:  J Virol Methods       Date:  1985-05       Impact factor: 2.014

5.  Diurnal changes in the plasma concentrations of corticosterone, luteinizing hormone and progesterone during sexual development and the ovulatory cycle of Khaki Campbell ducks.

Authors:  S C Wilson; F J Cunningham; T R Morris
Journal:  J Endocrinol       Date:  1982-05       Impact factor: 4.286

6.  Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

Authors:  Y Zhu; T Yamamoto; J Cullen; J Saputelli; C E Aldrich; D S Miller; S Litwin; P A Furman; A R Jilbert; W S Mason
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 7.  Lamivudine resistance in hepatitis B: mechanisms and clinical implications.

Authors:  K P Fischer; K S Gutfreund; D L Tyrrell
Journal:  Drug Resist Updat       Date:  2001-04       Impact factor: 18.500

8.  A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus.

Authors:  W R Addison; W W Wong; K P Fischer; D L Tyrrell
Journal:  Antiviral Res       Date:  2000-10       Impact factor: 5.970

9.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.

Authors:  J S Tuttleman; C Pourcel; J Summers
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

10.  Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver.

Authors:  R H Miller; W S Robinson
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

View more
  38 in total

Review 1.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

2.  Serum HBV RNA composition dynamics as a marker for intrahepatic HBV cccDNA turnover.

Authors:  Xupeng Hong; Jianming Hu
Journal:  J Med Virol       Date:  2020-06-02       Impact factor: 2.327

3.  A high level of mutation tolerance in the multifunctional sequence encoding the RNA encapsidation signal of an avian hepatitis B virus and slow evolution rate revealed by in vivo infection.

Authors:  Bernadette Schmid; Christine Rösler; Michael Nassal
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 4.  Hepatitis B virus replication.

Authors:  Juergen Beck; Michael Nassal
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

6.  Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus.

Authors:  Robert Yung-Liang Wang; Chia-Ning Shen; Min-Hui Lin; David Tosh; Chiaho Shih
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 7.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

Review 8.  Experimental models and therapeutic approaches for HBV.

Authors:  Maura Dandri; Marc Lütgehetmann; Jörg Petersen
Journal:  Semin Immunopathol       Date:  2012-08-17       Impact factor: 9.623

9.  Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.

Authors:  Aimee L Anderson; Krista E Banks; Marco Pontoglio; Moshe Yaniv; Alan McLachlan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 10.  Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.

Authors:  Maura Dandri; Joerg Petersen
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.